CPT 96372 (subcutaneous or intramuscular injection) pairs with J3111 and is separately billable in non-facility settings under most payers including Medicare
However, three major reviews didnt show sufficient evidence to support this claim (14, 15, 16)
02/06 FDA rev date: 9/15/2006 Side Effects for Nascobal The incidence of adverse experiences described in the Table below are based on data from a short-term clinical trial in vitamin B 12 deficient patients in hematologic remission receiving Nascobal (Cyanocobalamin, USP) Gel for Intranasal Administration (N=24) and intramuscular vitamin B 12 (N=25)
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
Vitamin D Injection Single high-dose IM GP-prescribed
After confirming a deficiency, doctors decide on the dosage and frequency of Vitamin B12 injections